ibogaine has been researched along with n-methylaspartate in 6 studies
| Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (n-methylaspartate) | Trials (n-methylaspartate) | Recent Studies (post-2010) (n-methylaspartate) |
|---|---|---|---|---|---|
| 445 | 8 | 136 | 10,408 | 59 | 1,902 |
| Protein | Taxonomy | ibogaine (IC50) | n-methylaspartate (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 5.175 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 5.175 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.175 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.175 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.175 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.175 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.175 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashim, A; Lajtha, A; Sershen, H | 2 |
| Glick, SD; Maisonneuve, IM; Pearl, SM | 1 |
| Scallet, AC; Ye, X | 1 |
| Couture, S; Debonnel, G | 1 |
| de Souza, DO; Elisabetsky, E; Leal, MB | 1 |
1 review(s) available for ibogaine and n-methylaspartate
| Article | Year |
|---|---|
Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies.
Topics: Animals; Brain; Cricetinae; Glutamic Acid; Humans; Hypothalamus; Ibogaine; Kainic Acid; Mice; N-Methylaspartate; Nerve Degeneration; Neurotoxins; Prion Diseases | 1997 |
5 other study(ies) available for ibogaine and n-methylaspartate
| Article | Year |
|---|---|
The effect of ibogaine on Sigma- and NMDA-receptor-mediated release of [3H]dopamine.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Ibogaine; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Pentazocine; Receptors, N-Methyl-D-Aspartate | 1996 |
Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine.
Topics: Animals; Corpus Striatum; Dopamine; Female; Ibogaine; Morphine; Motor Activity; N-Methylaspartate; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Self Administration; Substance-Related Disorders | 1997 |
Modulation of the neuronal response to N-methyl-D-aspartate by selective sigma2 ligands.
Topics: Animals; Electrophysiology; Ethylamines; Hippocampus; Ibogaine; Indoles; Injections, Intravenous; Ligands; Male; N-Methylaspartate; Neurons; Pyramidal Cells; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Spiro Compounds | 1998 |
Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release.
Topics: Animals; Behavior, Animal; Cocaine; Corpus Striatum; Culture Techniques; Dopamine; Drug Administration Schedule; Female; Ibogaine; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Perfusion; Pyrrolidines; Receptors, Opioid, kappa; Sex Factors | 1998 |
Long-lasting ibogaine protection against NMDA-induced convulsions in mice.
Topics: Animals; Cell Membrane; Cerebral Cortex; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Ibogaine; Male; Mice; Motor Activity; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Seizures | 2000 |